AL
DNMR

Aspiriant LLC’s Danimer Scientific, Inc. DNMR Stock Holding History

Aspiriant LLC’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-296
Closed -$5.38K – 311
2024
Q3 		$5.38K Hold
296
– – ﹤0.01% 292
2024
Q2 		$7.15K Hold
296
– – ﹤0.01% 281
2024
Q1 		$12.9K Hold
296
– – ﹤0.01% 316
2023
Q4 		$12.1K Hold
296
– – ﹤0.01% 307
2023
Q3 		$24.5K Hold
296
– – ﹤0.01% 280
2023
Q2 		$28.2K Hold
296
– – ﹤0.01% 281
2023
Q1 		$40.9K Hold
296
– – ﹤0.01% 274
2022
Q4 		$21.2K Hold
296
– – ﹤0.01% 277
2022
Q3 		$35K Hold
296
– – ﹤0.01% 261
2022
Q2 		$54K Buy
296
+46
+18% +$8.36K ﹤0.01% 270
2022
Q1 		$59K Buy
+250
New +$50.5K ﹤0.01% 272

Other funds holding DNMR

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Aspiriant LLC's DNMR Position: Q4 2024 in Review

Aspiriant LLC sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 296 shares — an estimated $5.38K sold.

Aspiriant LLC first reported a position in DNMR in Q1 2022 and held it in 11 quarters. The position peaked at $59K in Q1 2022. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Aspiriant LLC reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Aspiriant LLC sold 296 Danimer Scientific, Inc. shares in Q4 2024, an estimated $5.38K.
  • Aspiriant LLC first reported a position in Danimer Scientific, Inc. in Q1 2022 and held it in 11 quarters.
  • Aspiriant LLC's Danimer Scientific, Inc. position peaked at $59K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Aspiriant LLC's 13F filing for Q4 2024, filed 16 Jan 2025.